Search results
Prescription for trouble: Pennsylvania pharmacists say PBMs are driving pharmacy closures
Pennsylvania Capital-Star via Yahoo News· 6 days agoNow, they’re saying that time is here. Last year, more than 50 chain and independent pharmacies...
Our opinion: State must pursue PBM reform
Warren Times Observer· 5 days agoIt’s easy for our eyes to glass over when we hear state legislators are discussing legislation to reform the contract process between pharmacies and drug companies. Known as pharmacy ...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges...
Benzinga· 11 hours agoHumira, priced at nearly $7,000 per month, is the first high-selling drug to compete with numerous biosimilars. Following their launch last year, pharmacy benefit managers ...
Oscar Health Aims to More Than Double Membership by 2027
PYMNTS.com· 6 hours agoUsing its position in the Affordable Care Act market, Oscar Health aims to compete with larger...
As pharmacies disappear nationwide, Oregonians among the hardest hit
OregonLive.com· 4 days agoBrooklyn Pharmacy in Southeast Portland is a throwback to the days of mom-and-pop neighborhood...
Pharm Exec Exclusive: Mark Cuban Talks Drug Pricing
Pharmaceutical Executive Magazine· 1 day agoIn an email interview with Pharmaceutical Executive, Cuban stated that overcoming the challenge in providing affordable prescription drugs to the masses...
Oscar Health CEO Mark Bertolini is ready to take on the employer market
CNBC· 12 hours agoMark Bertolini has helped Oscar Health move toward profitability after taking over as CEO of the...
Time to Pounce: 2 Beaten-Down Ultra-High-Yield Dividend Stocks Begging to Be Bought in June
Motley Fool via Yahoo Finance· 4 days agoWentworth as its new CEO. Unlike Brewer, who had a retail background, Wentworth has decades of...
Ex-Cigna Executive Barred From Joining CVS, 8th Cir. Affirms (1)
Bloomberg Law· 2 days agoThe district court rightly found Amy Bricker’s two-year noncompete period is likely reasonable and enforceable because the health-care companies are each other’s chief rivals and “practically ...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 16 hours agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew...